| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.95e-06 | 14 | 136 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | G protein-coupled photoreceptor activity | 2.65e-06 | 15 | 136 | 4 | GO:0008020 | |
| GeneOntologyMolecularFunction | photoreceptor activity | 4.57e-06 | 17 | 136 | 4 | GO:0009881 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.65e-05 | 23 | 136 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 4.28e-05 | 29 | 136 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 4.28e-05 | 29 | 136 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 4.60e-05 | 2 | 136 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 4.60e-05 | 2 | 136 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 7.31e-05 | 149 | 136 | 7 | GO:1990782 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 8.15e-05 | 34 | 136 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.82e-04 | 230 | 136 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 2.44e-04 | 82 | 136 | 5 | GO:1990756 | |
| GeneOntologyMolecularFunction | glycolipid binding | 3.44e-04 | 49 | 136 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 4.83e-04 | 95 | 136 | 5 | GO:0140767 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 5.36e-04 | 55 | 136 | 4 | GO:0042974 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase binding | 8.02e-04 | 27 | 136 | 3 | GO:0070696 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 9.46e-04 | 7 | 136 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 9.46e-04 | 7 | 136 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | lipid binding | PAQR9 RASGRP4 PSG2 PSG4 CYP4A11 BCAS3 PSG9 GAS6 PAQR6 SYT7 CYP4A22 RNASE7 PITPNM3 PSG8 ALOX15 PAQR7 | 1.14e-03 | 988 | 136 | 16 | GO:0008289 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.33e-03 | 70 | 136 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.56e-03 | 73 | 136 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | receptor serine/threonine kinase binding | 1.72e-03 | 35 | 136 | 3 | GO:0033612 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 2.00e-03 | 10 | 136 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 2.00e-03 | 10 | 136 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 2.00e-03 | 10 | 136 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.27e-03 | 196 | 136 | 6 | GO:0005319 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 1.94e-08 | 71 | 134 | 8 | GO:0043114 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | PSG2 PSG4 PSG9 GAS6 PRAMEF1 PRAMEF2 F2RL1 PRAMEF13 CXCR4 PRAMEF14 PKHD1 PSG8 ALOX15 | 1.41e-06 | 385 | 134 | 13 | GO:0070372 |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.62e-06 | 14 | 134 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.88e-06 | 32 | 134 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 2.15e-06 | 91 | 134 | 7 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 2.20e-06 | 15 | 134 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 2.20e-06 | 15 | 134 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 2.20e-06 | 15 | 134 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.20e-06 | 15 | 134 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 2.48e-06 | 93 | 134 | 7 | GO:1900046 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.57e-06 | 34 | 134 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 2.92e-06 | 16 | 134 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 3.08e-06 | 96 | 134 | 7 | GO:0050818 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | PSG2 PSG4 PSG9 GAS6 PRAMEF1 PRAMEF2 F2RL1 PRAMEF13 CXCR4 PRAMEF14 PKHD1 PSG8 ALOX15 | 3.47e-06 | 418 | 134 | 13 | GO:0070371 |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 3.80e-06 | 17 | 134 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 3.80e-06 | 17 | 134 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 3.80e-06 | 17 | 134 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 4.84e-06 | 67 | 134 | 6 | GO:0045601 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 4.85e-06 | 246 | 134 | 10 | GO:0045216 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 4.86e-06 | 18 | 134 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | blood circulation | ABR PSG2 PSG4 PSG9 ADM2 GAS6 F2RL1 BMP6 CXCR4 WDR35 HRH1 SERPING1 CLDN5 PSG8 ATP1B2 SMAD7 | 4.90e-06 | 648 | 134 | 16 | GO:0008015 |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 5.76e-06 | 69 | 134 | 6 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 6.26e-06 | 70 | 134 | 6 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 7.39e-06 | 72 | 134 | 6 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 7.61e-06 | 20 | 134 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 9.14e-06 | 158 | 134 | 8 | GO:0045446 | |
| GeneOntologyBiologicalProcess | MAPK cascade | PSG2 HACD3 PSG4 PSG9 GAS6 NAIP PRAMEF1 PRAMEF2 F2RL1 PRAMEF13 MAP3K4 HIPK3 CXCR4 PRAMEF14 MAPKAPK3 PKHD1 PSG8 ALOX15 KLB | 9.25e-06 | 930 | 134 | 19 | GO:0000165 |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 9.36e-06 | 21 | 134 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 9.36e-06 | 21 | 134 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 9.36e-06 | 21 | 134 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.14e-05 | 22 | 134 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 1.25e-05 | 217 | 134 | 9 | GO:1903034 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 1.31e-05 | 166 | 134 | 8 | GO:0002698 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 1.31e-05 | 166 | 134 | 8 | GO:0061041 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.32e-05 | 47 | 134 | 5 | GO:0034104 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.37e-05 | 23 | 134 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.37e-05 | 23 | 134 | 4 | GO:0002858 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 1.57e-05 | 344 | 134 | 11 | GO:0003018 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.64e-05 | 24 | 134 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.64e-05 | 24 | 134 | 4 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.64e-05 | 24 | 134 | 4 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.94e-05 | 25 | 134 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.94e-05 | 25 | 134 | 4 | GO:0002423 | |
| GeneOntologyBiologicalProcess | wound healing | PSG2 PSG4 PSG9 GAS6 GATA2 LCP1 F2RL1 SYT7 CXCR4 SERPING1 PLAT PSG8 ALOX15 | 2.02e-05 | 493 | 134 | 13 | GO:0042060 |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | PSG2 PSG4 PSG9 GAS6 NAIP PRAMEF1 PRAMEF2 F2RL1 PRAMEF13 MAP3K4 HIPK3 CXCR4 PRAMEF14 PKHD1 PSG8 ALOX15 KLB | 2.19e-05 | 815 | 134 | 17 | GO:0043408 |
| GeneOntologyBiologicalProcess | circulatory system process | ABR PSG2 PSG4 PSG9 ADM2 GAS6 F2RL1 BMP6 CXCR4 WDR35 HRH1 SERPING1 CLDN5 PSG8 ATP1B2 SMAD7 | 2.26e-05 | 733 | 134 | 16 | GO:0003013 |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 2.40e-05 | 53 | 134 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | endothelium development | 2.55e-05 | 182 | 134 | 8 | GO:0003158 | |
| GeneOntologyBiologicalProcess | response to wounding | PSG2 PSG4 PSG9 GAS6 GATA2 LCP1 F2RL1 SYT7 FOSL1 PTPRF CXCR4 SERPING1 PLAT PSG8 ALOX15 | 2.56e-05 | 659 | 134 | 15 | GO:0009611 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.66e-05 | 27 | 134 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 2.85e-05 | 91 | 134 | 6 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis | 3.04e-05 | 136 | 134 | 7 | GO:0050764 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 3.09e-05 | 28 | 134 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 3.57e-05 | 29 | 134 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 3.86e-05 | 96 | 134 | 6 | GO:0002704 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 4.33e-05 | 98 | 134 | 6 | GO:0061045 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 4.40e-05 | 60 | 134 | 5 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 4.68e-05 | 31 | 134 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 5.32e-05 | 32 | 134 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 5.32e-05 | 32 | 134 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 6.02e-05 | 33 | 134 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 6.02e-05 | 33 | 134 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 6.79e-05 | 34 | 134 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 7.63e-05 | 35 | 134 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-1 production | 1.03e-04 | 165 | 134 | 7 | GO:0032652 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.06e-04 | 38 | 134 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 1.06e-04 | 72 | 134 | 5 | GO:0032692 | |
| GeneOntologyBiologicalProcess | blood vessel development | PSG2 PSG4 BCAS3 PSG9 ADM2 GATA2 ITGA7 FOSL1 JAK1 TGFBR2 CXCR4 WIF1 PKNOX1 CLDN5 PSG8 MYO18B SMAD7 | 1.11e-04 | 929 | 134 | 17 | GO:0001568 |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | RASGRP4 ABR PSG2 PSG4 PSG9 MAS1 DAPK2 GAS6 NAIP F2RL1 FOSL1 BMP6 PTPRF CXCR4 MAPKAPK3 SERPING1 PLAT PSG8 ALOX15 MVK NLRP5 | 1.16e-04 | 1316 | 134 | 21 | GO:0032101 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.17e-04 | 39 | 134 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 1.22e-04 | 118 | 134 | 6 | GO:0001570 | |
| GeneOntologyBiologicalProcess | lauric acid metabolic process | 1.25e-04 | 3 | 134 | 2 | GO:0048252 | |
| GeneOntologyBiologicalProcess | interleukin-1 production | 1.29e-04 | 171 | 134 | 7 | GO:0032612 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.30e-04 | 40 | 134 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.43e-04 | 41 | 134 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.57e-04 | 42 | 134 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 1.72e-04 | 239 | 134 | 8 | GO:0050777 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.75e-04 | 80 | 134 | 5 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 1.75e-04 | 80 | 134 | 5 | GO:0046850 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.75e-04 | 126 | 134 | 6 | GO:1903035 | |
| GeneOntologyBiologicalProcess | vasculature development | PSG2 PSG4 BCAS3 PSG9 ADM2 GATA2 ITGA7 FOSL1 JAK1 TGFBR2 CXCR4 WIF1 PKNOX1 CLDN5 PSG8 MYO18B SMAD7 | 1.84e-04 | 969 | 134 | 17 | GO:0001944 |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 1.91e-04 | 128 | 134 | 6 | GO:0034103 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 1.92e-04 | 309 | 134 | 9 | GO:0002703 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.06e-04 | 45 | 134 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.08e-04 | 83 | 134 | 5 | GO:0002707 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 2.25e-04 | 46 | 134 | 4 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 2.25e-04 | 46 | 134 | 4 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 2.32e-04 | 85 | 134 | 5 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 2.32e-04 | 85 | 134 | 5 | GO:1903670 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | PSG2 PSG4 PSG9 GAS6 MYORG JAK1 TGFBR2 BMP6 MTMR4 PTPRF PIP4K2A MAPKAPK3 WIF1 PLAT CLDN5 PSG8 SMAD7 PLCE1 KLB | 2.41e-04 | 1186 | 134 | 19 | GO:0007167 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.45e-04 | 47 | 134 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 2.45e-04 | 47 | 134 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 2.45e-04 | 86 | 134 | 5 | GO:0042058 | |
| GeneOntologyBiologicalProcess | positive regulation of glomerular filtration | 2.49e-04 | 4 | 134 | 2 | GO:0003104 | |
| GeneOntologyBiologicalProcess | folic acid catabolic process | 2.49e-04 | 4 | 134 | 2 | GO:0046657 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 2.59e-04 | 87 | 134 | 5 | GO:0001974 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 2.66e-04 | 48 | 134 | 4 | GO:0043277 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | PSG2 PSG4 BCAS3 PSG9 ADM2 GATA2 ITGA7 JAK1 TGFBR2 CXCR4 PKNOX1 CLDN5 PSG8 MYO18B SMAD7 | 2.78e-04 | 817 | 134 | 15 | GO:0048514 |
| GeneOntologyBiologicalProcess | liver morphogenesis | 2.88e-04 | 49 | 134 | 4 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 2.88e-04 | 49 | 134 | 4 | GO:0002837 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 4.63e-08 | 16 | 137 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | cilium | CATSPERE TTLL3 PSG2 PSG4 PSG9 OPN1LW OPN1MW PRAMEF1 PRAMEF2 NPHP4 PRAMEF13 CCDC38 OPN1MW2 OPN1MW3 DNAH17 PIP4K2A PKHD1 WDR35 CATSPERB PSG8 CFAP46 | 4.00e-07 | 898 | 137 | 21 | GO:0005929 |
| GeneOntologyCellularComponent | photoreceptor disc membrane | 2.36e-05 | 26 | 137 | 4 | GO:0097381 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.81e-05 | 90 | 137 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 6.81e-05 | 153 | 137 | 7 | GO:0097731 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 2.53e-04 | 47 | 137 | 4 | GO:0031462 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 3.12e-04 | 139 | 137 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | non-motile cilium | 3.15e-04 | 196 | 137 | 7 | GO:0097730 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 3.72e-04 | 335 | 137 | 9 | GO:0061695 | |
| GeneOntologyCellularComponent | apical part of cell | SLC6A18 PSG2 PSG4 CYP4A11 PSG9 CYP4A22 PKHD1 PLAT PSG8 ATP1B2 SLC14A2 NLRP5 | 5.32e-04 | 592 | 137 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | photoreceptor outer segment | 8.26e-04 | 111 | 137 | 5 | GO:0001750 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC6A18 PSG2 PSG4 CYP4A11 PSG9 CYP4A22 PKHD1 PSG8 ATP1B2 SLC14A2 | 1.41e-03 | 487 | 137 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | transferase complex | PSG2 PSG4 PSG9 POLD2 POLR2A POLR1C PRAMEF1 PRAMEF2 PRAMEF13 TGFBR2 ORMDL1 SF3B3 PRAMEF14 PSG8 UGT3A2 | 1.64e-03 | 963 | 137 | 15 | GO:1990234 |
| GeneOntologyCellularComponent | anchoring junction | PSG2 HACD3 PSG4 PSG9 TBC1D2 ITGA7 LCP1 NPHP4 PABPC1 JAK1 CXCR4 CLDN5 PSG8 SNTB2 SMAD7 | 1.87e-03 | 976 | 137 | 15 | GO:0070161 |
| MousePheno | increased skeletal muscle triglyceride level | 5.30e-07 | 21 | 111 | 5 | MP:0031415 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 4.16e-06 | 31 | 111 | 5 | MP:0031413 | |
| MousePheno | increased renal vascular resistance | 4.82e-06 | 5 | 111 | 3 | MP:0005531 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 8.28e-06 | 17 | 111 | 4 | MP:0031047 | |
| MousePheno | abnormal muscle triglyceride level | 8.93e-06 | 36 | 111 | 5 | MP:0031412 | |
| MousePheno | abnormal renal vascular resistance | 2.65e-05 | 8 | 111 | 3 | MP:0005529 | |
| MousePheno | abnormal renal transport | 2.97e-05 | 23 | 111 | 4 | MP:0011417 | |
| MousePheno | decreased fatty acid oxidation | 3.54e-05 | 24 | 111 | 4 | MP:0014172 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 4.16e-05 | 49 | 111 | 5 | MP:0020948 | |
| MousePheno | increased abdominal fat pad weight | 5.74e-05 | 27 | 111 | 4 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 6.66e-05 | 28 | 111 | 4 | MP:0020950 | |
| MousePheno | decreased carbon dioxide production | 1.00e-04 | 31 | 111 | 4 | MP:0008964 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.63e-04 | 35 | 111 | 4 | MP:0031618 | |
| MousePheno | decreased muscle cell glucose uptake | 2.50e-04 | 39 | 111 | 4 | MP:0030022 | |
| MousePheno | abnormal incidence of induced tumors | 2.89e-04 | 269 | 111 | 9 | MP:0013151 | |
| MousePheno | increased circulating amylase level | 3.67e-04 | 119 | 111 | 6 | MP:0008806 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 4.00e-04 | 44 | 111 | 4 | MP:0031023 | |
| MousePheno | abnormal vascular resistance | 4.30e-04 | 19 | 111 | 3 | MP:0005532 | |
| MousePheno | increased incidence of induced tumors | 4.54e-04 | 173 | 111 | 7 | MP:0002021 | |
| MousePheno | abnormal spermatogonia proliferation | 5.16e-04 | 47 | 111 | 4 | MP:0002685 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 5.16e-04 | 47 | 111 | 4 | MP:0031617 | |
| Domain | Opsin_red/grn | 3.37e-07 | 3 | 131 | 3 | IPR000378 | |
| Domain | OPSIN | 3.90e-05 | 10 | 131 | 3 | PS00238 | |
| Domain | HlyIII | 5.34e-05 | 11 | 131 | 3 | PF03006 | |
| Domain | Opsin | 5.34e-05 | 11 | 131 | 3 | IPR001760 | |
| Domain | AdipoR/HlyIII-related | 5.34e-05 | 11 | 131 | 3 | IPR004254 | |
| Domain | PRAME_family | 3.01e-04 | 19 | 131 | 3 | IPR026271 | |
| Pathway | REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION | 1.89e-05 | 8 | 100 | 3 | MM14880 | |
| Pathway | REACTOME_OPSINS | 4.01e-05 | 10 | 100 | 3 | MM15063 | |
| Pubmed | Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy. | 2.44e-10 | 4 | 139 | 4 | 29386880 | |
| Pubmed | Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. | 1.22e-09 | 5 | 139 | 4 | 2937147 | |
| Pubmed | Regulation of the epithelial adhesion molecule CEACAM1 is important for palate formation. | 4.00e-09 | 16 | 139 | 5 | 23613893 | |
| Pubmed | In vivo validation of late-onset Alzheimer's disease genetic risk factors. | 4.73e-08 | 25 | 139 | 5 | 38687251 | |
| Pubmed | Multiple hypothalamic cell populations encoding distinct visual information. | 6.25e-08 | 3 | 139 | 3 | 21224225 | |
| Pubmed | Circadian Regulation of the Rod Contribution to Mesopic Vision in Mice. | 6.25e-08 | 3 | 139 | 3 | 36216501 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 34111401 | ||
| Pubmed | Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy. | 6.25e-08 | 3 | 139 | 3 | 28751656 | |
| Pubmed | The molecular genetics and evolution of red and green color vision in vertebrates. | 6.25e-08 | 3 | 139 | 3 | 11545071 | |
| Pubmed | Co-expression of murine opsins facilitates identifying the site of cone adaptation. | 6.25e-08 | 3 | 139 | 3 | 12511072 | |
| Pubmed | Molecular determinants of human red/green color discrimination. | 6.25e-08 | 3 | 139 | 3 | 8185948 | |
| Pubmed | X-linked cone dystrophy caused by mutation of the red and green cone opsins. | 6.25e-08 | 3 | 139 | 3 | 20579627 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 38410159 | ||
| Pubmed | Chloride-dependent spectral tuning mechanism of L-group cone visual pigments. | 6.25e-08 | 3 | 139 | 3 | 23350963 | |
| Pubmed | Distinct contributions of rod, cone, and melanopsin photoreceptors to encoding irradiance. | 6.25e-08 | 3 | 139 | 3 | 20471354 | |
| Pubmed | Spectral tuning of a circadian photopigment in a subterranean 'blind' mammal (Spalax ehrenbergi). | 6.25e-08 | 3 | 139 | 3 | 10567724 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 14500905 | ||
| Pubmed | Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy. | 6.25e-08 | 3 | 139 | 3 | 31469404 | |
| Pubmed | Mechanisms of spectral tuning in the mouse green cone pigment. | 6.25e-08 | 3 | 139 | 3 | 9238068 | |
| Pubmed | Emergence of novel color vision in mice engineered to express a human cone photopigment. | 6.25e-08 | 3 | 139 | 3 | 17379811 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 7958444 | ||
| Pubmed | 8.66e-08 | 28 | 139 | 5 | 25089626 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.70e-07 | 13 | 139 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.70e-07 | 13 | 139 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.70e-07 | 13 | 139 | 4 | 16638824 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 20044046 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 32150576 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 6265583 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.70e-07 | 13 | 139 | 4 | 12832451 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.70e-07 | 13 | 139 | 4 | 21670291 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 22162753 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 2702644 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 8380065 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 1279194 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 25724769 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.70e-07 | 13 | 139 | 4 | 22092845 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 11801635 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.70e-07 | 13 | 139 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.70e-07 | 13 | 139 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.70e-07 | 13 | 139 | 4 | 23800882 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 19285068 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 21760897 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.70e-07 | 13 | 139 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.70e-07 | 13 | 139 | 4 | 39168268 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 8402684 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 16619040 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.70e-07 | 13 | 139 | 4 | 8209741 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.70e-07 | 13 | 139 | 4 | 21949477 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 26219866 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 2133556 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 32521208 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 19406938 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.70e-07 | 13 | 139 | 4 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.70e-07 | 13 | 139 | 4 | 19358828 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 16680193 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.70e-07 | 13 | 139 | 4 | 34058224 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 10964771 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 32169849 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.70e-07 | 13 | 139 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.70e-07 | 13 | 139 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.70e-07 | 13 | 139 | 4 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.70e-07 | 13 | 139 | 4 | 23935487 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 15331748 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.70e-07 | 13 | 139 | 4 | 22406619 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.70e-07 | 13 | 139 | 4 | 25972571 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 19008452 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.70e-07 | 13 | 139 | 4 | 15220458 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 18843289 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 15207636 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 21081647 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 11133662 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 11483763 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 2164599 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 29396368 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 18003729 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.70e-07 | 13 | 139 | 4 | 33352461 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 38381498 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 20739537 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.70e-07 | 13 | 139 | 4 | 27695943 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 20404914 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.70e-07 | 13 | 139 | 4 | 32027621 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.70e-07 | 13 | 139 | 4 | 27777319 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 18848945 | ||
| Cytoband | 1p36.21 | 1.44e-06 | 63 | 139 | 5 | 1p36.21 | |
| Cytoband | 12q24.21 | 9.05e-05 | 5 | 139 | 2 | 12q24.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 6.80e-04 | 346 | 139 | 6 | chr17p13 | |
| Cytoband | 1p34.2 | 7.05e-04 | 57 | 139 | 3 | 1p34.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 2.60e-07 | 11 | 98 | 4 | 1315 | |
| GeneFamily | Opsin receptors | 2.60e-07 | 11 | 98 | 4 | 215 | |
| GeneFamily | PRAME family | 7.93e-06 | 24 | 98 | 4 | 686 | |
| GeneFamily | Progestin and adipoQ receptor family | 2.47e-05 | 11 | 98 | 3 | 930 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 1.18e-06 | 201 | 137 | 9 | MM1294 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 1.04e-05 | 199 | 137 | 8 | M5406 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | PSG2 HACD3 PSG4 PSG9 LCP1 ACYP1 HIPK3 JAK1 TGFBR2 PTPRF PIP4K2A CLDN5 PSG8 KLB | 1.59e-05 | 689 | 137 | 14 | MM1041 |
| Coexpression | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN | 1.63e-05 | 10 | 137 | 3 | MM560 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | PSG2 HACD3 PSG4 PSG9 LCP1 ACYP1 HIPK3 JAK1 TGFBR2 PTPRF PIP4K2A CLDN5 PSG8 KLB | 1.73e-05 | 694 | 137 | 14 | MM1039 |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 2.29e-05 | 32 | 137 | 4 | MM2 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | PSG2 PSG4 PSG9 IGHV1-3 POLR1C LCP1 PABPC1 CHRNB1 PTPRF PKHD1 CES3 PSG8 | 2.50e-05 | 534 | 137 | 12 | MM1050 |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 3.30e-05 | 35 | 137 | 4 | MM757 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 4.66e-05 | 75 | 137 | 5 | MM605 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | CUX2 PSG2 PSG4 PSG9 POLR1C FRYL TSPYL1 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 HRH1 SERPING1 PSG8 REXO1L1P | 5.29e-05 | 871 | 137 | 15 | MM1005 |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 6.55e-05 | 190 | 137 | 7 | MM1311 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 7.90e-05 | 135 | 137 | 6 | MM965 | |
| Coexpression | GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 8.48e-05 | 198 | 137 | 7 | M7944 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.16e-04 | 48 | 137 | 4 | MM531 | |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_3D_UP | 1.19e-04 | 209 | 137 | 7 | M17026 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 183 | 138 | 7 | a253ad65673fce6cb453e709cb235ce7cbfa18b7 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 183 | 138 | 7 | ddc45fb591ba0ce3fa05c08051d58286a89ef835 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-06 | 195 | 138 | 7 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-F|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.77e-06 | 197 | 138 | 7 | fbff2fb7a8142b88c9dc71aa10980f4350b7e081 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.90e-05 | 177 | 138 | 6 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 179 | 138 | 6 | 6f51a4580c06fc55cc764052c9b26f7c55660282 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 179 | 138 | 6 | f14440f6ce9b4fcdd4bcb2488b949f9a0e17bc23 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 179 | 138 | 6 | a6ce1fa338d4905bd6afef00763ac83e916a0b37 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.16e-05 | 181 | 138 | 6 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 183 | 138 | 6 | 25c96df8ea0c7bbedbb7699ee84ad6234d19cba8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.52e-05 | 186 | 138 | 6 | 71e87c4c755ab607689cb050f5a363cb520a0f53 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.59e-05 | 187 | 138 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.67e-05 | 188 | 138 | 6 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 189 | 138 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 189 | 138 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 2.75e-05 | 189 | 138 | 6 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 190 | 138 | 6 | 97772e69e6f51ebffbb5433ca7b40f1048723220 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 190 | 138 | 6 | 72c2b824acdc43139e6635785df3ed3feb58ec46 | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 191 | 138 | 6 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.92e-05 | 191 | 138 | 6 | 402c341b00f98e8215458766b3c219fff8dcb447 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-05 | 192 | 138 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-05 | 193 | 138 | 6 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-05 | 193 | 138 | 6 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 194 | 138 | 6 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-05 | 194 | 138 | 6 | 95dfbd9d9b8a47801edcfc35fb0d685901dcd2f8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 194 | 138 | 6 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-05 | 194 | 138 | 6 | 2507f6dc7f1fe8b91fe1e24497d26d05afc3cd21 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.19e-05 | 194 | 138 | 6 | ca1f24070424b44b7a442e4fca761ebfbe24b063 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 195 | 138 | 6 | 3f64e2313ec79a6d5f4013a52722d071172f6c5d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 195 | 138 | 6 | 7a5108335353ac160b684650c5da97d6f7f4dbcf | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.38e-05 | 196 | 138 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.38e-05 | 196 | 138 | 6 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-05 | 196 | 138 | 6 | ed6047b48b6a96baa6a90c7af784e7c34b32824d | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 196 | 138 | 6 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 196 | 138 | 6 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-05 | 197 | 138 | 6 | 759f26753f76af3ae8d8527c4d221206245a3d45 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.47e-05 | 197 | 138 | 6 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 3.47e-05 | 197 | 138 | 6 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-05 | 197 | 138 | 6 | 1c0024049db2d2c817a7f503de235b9630b24e33 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-05 | 197 | 138 | 6 | c29ed0e706999d4c2b93e6e3bf46c42aeceb4813 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 198 | 138 | 6 | 0c8ec287500c58938ecc0dbbbc5f6c7a48733fc6 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-05 | 199 | 138 | 6 | 07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-gdT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-05 | 199 | 138 | 6 | 74d53ad732dd29ad84d81f9c72f586f6c7bc5c57 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-SPP1+_Mac|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.67e-05 | 199 | 138 | 6 | d94cf750599366061066074e8007d707adf6fc5a | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.78e-05 | 200 | 138 | 6 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-Mesoderm|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.78e-05 | 200 | 138 | 6 | 9ef226ebb0a7cdb9431e2fa65faa2a7d67da590d | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|Control_saline / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | 58b25dc2d29e98354bfc8e8e161796c237c3dc23 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.78e-05 | 200 | 138 | 6 | cd3c638961144a2fc91c437a173cc37c7452fa74 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.92e-05 | 133 | 138 | 5 | bc29a2faa151b0e48c1c7e3f016cccc49f9a15eb | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 9.82e-05 | 148 | 138 | 5 | de35eeefad0e27a0d127e2e4bedead2bddb75152 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_C|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.08e-04 | 151 | 138 | 5 | 3f2abaa42876ce7a71d934ff16abe0cab0991a05 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-myeloid_DC_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-04 | 152 | 138 | 5 | bffbbdf1047c59e5241c99dc10b36cfe2071aa48 | |
| ToppCell | PND01-03-samps-Epithelial-Epithelial-non_alveolar|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.15e-04 | 153 | 138 | 5 | fc0d2d50aa3b6b2772bbf3626c9df5c5e8d7d11e | |
| ToppCell | PND01-03-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.15e-04 | 153 | 138 | 5 | 2482247d9c39c7b99bb45fb9153442f64fd6012f | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-04 | 154 | 138 | 5 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | droplet-Heart-nan-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 158 | 138 | 5 | 81a5a73090804d41429d297ba2462a842f39d380 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-cardiac_mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 158 | 138 | 5 | 9596b7b0f6f5157a43d67d2e67fb75a2624a6bb9 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 158 | 138 | 5 | 7ebc8b778c97c0faa79e2d80c98b887fa635f901 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 158 | 138 | 5 | d43b335e6aa12d84a75b988fbd6127ff1f4af25c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 158 | 138 | 5 | ab12b29ce51ca2fcac469cc932391217d97145f9 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 162 | 138 | 5 | 34b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-04 | 162 | 138 | 5 | 4b9f80f701dcbb2508f497095cb8a7a2ca51cb5e | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.54e-04 | 163 | 138 | 5 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 164 | 138 | 5 | 662f74ad2656c0af158dbf9eb81d5bf70f54e529 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-04 | 167 | 138 | 5 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-04 | 167 | 138 | 5 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-04 | 167 | 138 | 5 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-04 | 167 | 138 | 5 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 1.73e-04 | 167 | 138 | 5 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 169 | 138 | 5 | 605cc2638271803cf1d972ab3fa8f13f89666376 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 169 | 138 | 5 | 337be3bf485b54afad86e256cb0c4c1d0c2a9a2a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-04 | 170 | 138 | 5 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | Myeloid-Myeloid-D_(Mast_cell)|Myeloid / shred on cell class and cell subclass (v4) | 1.93e-04 | 171 | 138 | 5 | 5f1aafc4c55a9c6c3153430186a8a351425a3cb9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.93e-04 | 171 | 138 | 5 | e6dfbd2652b67577c8834c05348f62150637f348 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.93e-04 | 171 | 138 | 5 | ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 172 | 138 | 5 | 0457ccc18697aaec44b7c30ae157aae8f48d8785 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 173 | 138 | 5 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-04 | 173 | 138 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 174 | 138 | 5 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 174 | 138 | 5 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-04 | 174 | 138 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | PSB-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.32e-04 | 178 | 138 | 5 | 45bdbb96094c97756e1b6eebd80eadd8472143f2 | |
| ToppCell | Endothelial-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.32e-04 | 178 | 138 | 5 | 2f2602b9305d55f25afa9861dd6c6347ae179337 | |
| ToppCell | Endothelial-A-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.38e-04 | 179 | 138 | 5 | 138fd6ba6bdbd0ad01c574168addf720b67a0fea | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-04 | 180 | 138 | 5 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-migDC|Lung / Manually curated celltypes from each tissue | 2.45e-04 | 180 | 138 | 5 | e9e8992deb0beeee5548910e4616e7c990763d99 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-04 | 180 | 138 | 5 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.45e-04 | 180 | 138 | 5 | 1c5515f29ead129bee3b4ca27799796956811a39 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-04 | 180 | 138 | 5 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-04 | 181 | 138 | 5 | 61c6e000db7047fda4b4bb5024f3af24577e7d29 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 181 | 138 | 5 | c26d3cbbc592299786d79d1b15fc6bead2aafb9a | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 181 | 138 | 5 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-04 | 182 | 138 | 5 | c7e07570480295e1ad3c5fbbb16b8e4df90c690d | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-04 | 182 | 138 | 5 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 183 | 138 | 5 | f524501dec1dccbf44100a61395116e4525bdc89 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.64e-04 | 183 | 138 | 5 | 6e5b39c0170d62eb7fdd411dcfff51ed176573d0 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.64e-04 | 183 | 138 | 5 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.64e-04 | 183 | 138 | 5 | 6821dca076318115d360ff426eb1218cfe104063 | |
| Disease | blue cone monochromacy (implicated_via_orthology) | 3.94e-10 | 4 | 133 | 4 | DOID:0050679 (implicated_via_orthology) | |
| Disease | cD177 antigen measurement | 1.15e-06 | 18 | 133 | 4 | EFO_0021866 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.44e-05 | 11 | 133 | 3 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | Cone monochromatism | 2.02e-05 | 2 | 133 | 2 | cv:C0339537 | |
| Disease | BORNHOLM EYE DISEASE | 2.02e-05 | 2 | 133 | 2 | C3159311 | |
| Disease | Achromatopsia incomplete, X-linked | 2.02e-05 | 2 | 133 | 2 | C2931753 | |
| Disease | Red-green dyschromatopsia | 2.02e-05 | 2 | 133 | 2 | cv:C0155016 | |
| Disease | Cone monochromatism | 2.02e-05 | 2 | 133 | 2 | C0339537 | |
| Disease | BLUE CONE MONOCHROMACY | 2.02e-05 | 2 | 133 | 2 | 303700 | |
| Disease | blue cone monochromacy (is_implicated_in) | 2.02e-05 | 2 | 133 | 2 | DOID:0050679 (is_implicated_in) | |
| Disease | ventricular enlargement measurement | 2.48e-05 | 13 | 133 | 3 | EFO_0010570 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 3.92e-05 | 15 | 133 | 3 | DOID:4074 (is_implicated_in) | |
| Disease | blood urea nitrogen measurement | 4.06e-05 | 452 | 133 | 10 | EFO_0004741 | |
| Disease | pulse pressure measurement | PAQR9 DIP2B CUX2 MTERF1 GATA2 LLPH FRYL MED13L LCP1 ADAMTSL3 BMP6 PIP4K2A PITPNM3 HRH1 SLC14A2 NUP160 PLCE1 KLB | 5.52e-05 | 1392 | 133 | 18 | EFO_0005763 |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 1.20e-04 | 4 | 133 | 2 | EFO_0801909 | |
| Disease | Iminoglycinuria | 1.20e-04 | 4 | 133 | 2 | C0268654 | |
| Disease | fatty acid measurement | 1.68e-04 | 436 | 133 | 9 | EFO_0005110 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0801907 | |
| Disease | X-14939 measurement | 2.99e-04 | 6 | 133 | 2 | EFO_0800747 | |
| Disease | Cone-Rod Dystrophy 2 | 3.00e-04 | 29 | 133 | 3 | C3489532 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0801906 | |
| Disease | X-12244--N-acetylcarnosine measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0021299 | |
| Disease | blood N-acetylcarnosine measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0022217 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 4.35e-04 | 78 | 133 | 4 | EFO_0022187 | |
| Disease | N-acetylcarnosine measurement | 5.55e-04 | 8 | 133 | 2 | EFO_0022101 | |
| Disease | Pruritus | 5.55e-04 | 8 | 133 | 2 | C0033774 | |
| Disease | alkaline phosphatase measurement | CUX2 GAS6 LCP1 ZFAND4 JAK1 PIP4K2A ENTPD6 PCIF1 SERPING1 LRBA NUP160 SMAD7 PLCE1 | 6.94e-04 | 1015 | 133 | 13 | EFO_0004533 |
| Disease | cognitive function measurement | SZT2 POLR2A VPS8 ZBTB9 ADAMTSL3 SYT7 GALNT18 CHRNB1 JAK1 PTPRF PKHD1 SERPING1 C2 UGT3A2 MYO18B SLC14A2 | 7.50e-04 | 1434 | 133 | 16 | EFO_0008354 |
| Disease | Marfan syndrome (implicated_via_orthology) | 8.86e-04 | 10 | 133 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | mitochondrial complex I deficiency (implicated_via_orthology) | 8.86e-04 | 10 | 133 | 2 | DOID:0060536 (implicated_via_orthology) | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 1.08e-03 | 11 | 133 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | smoking status measurement, forced expiratory volume | 1.08e-03 | 11 | 133 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | eosinophil count | DIP2B RASGRP4 CUX2 MTERF1 ZBTB9 LCP1 FOSL1 OPN1MW2 JAK1 OPN1MW3 RESF1 CXCR4 ENTPD6 UGT3A2 ALOX15 SMAD7 | 1.11e-03 | 1488 | 133 | 16 | EFO_0004842 |
| Disease | Thrombus | 1.18e-03 | 46 | 133 | 3 | C0087086 | |
| Disease | Congenital neutropenia | 1.29e-03 | 12 | 133 | 2 | C0340970 | |
| Disease | Thromboembolism | 1.29e-03 | 12 | 133 | 2 | C0040038 | |
| Disease | alcohol consumption measurement, alcohol drinking | 1.29e-03 | 12 | 133 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | Colorectal Carcinoma | TTLL3 ADAMTSL3 TGFBR2 BMP6 WIF1 PKHD1 PKNOX1 HRH1 UGT3A2 SMAD7 | 1.34e-03 | 702 | 133 | 10 | C0009402 |
| Disease | Alzheimer disease, polygenic risk score | 1.39e-03 | 586 | 133 | 9 | EFO_0030082, MONDO_0004975 | |
| Disease | Thrombosis | 1.42e-03 | 49 | 133 | 3 | C0040053 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.52e-03 | 13 | 133 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | esophageal squamous cell carcinoma | 1.52e-03 | 13 | 133 | 2 | EFO_0005922 | |
| Disease | factor XI measurement, coronary artery disease | 1.85e-03 | 115 | 133 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | triglycerides in medium HDL measurement | 1.88e-03 | 54 | 133 | 3 | EFO_0022321 | |
| Disease | triglycerides in LDL measurement | 2.08e-03 | 56 | 133 | 3 | EFO_0022320 | |
| Disease | eosinophil percentage of leukocytes | RASGRP4 LCP1 FOSL1 OPN1MW2 JAK1 OPN1MW3 RESF1 CXCR4 ALOX15 SMAD7 | 2.09e-03 | 746 | 133 | 10 | EFO_0007991 |
| Disease | sugar consumption measurement | 2.16e-03 | 120 | 133 | 4 | EFO_0010158 | |
| Disease | Atherosclerosis | 2.42e-03 | 59 | 133 | 3 | C0004153 | |
| Disease | Atherogenesis | 2.42e-03 | 59 | 133 | 3 | C1563937 | |
| Disease | monocyte count | RASGRP4 STAG1 SZT2 BCAS3 ARHGAP30 MED13L F2RL1 FOSL1 PPIG CXCR4 CES3 HYI MVK PLCE1 | 2.58e-03 | 1320 | 133 | 14 | EFO_0005091 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.66e-03 | 61 | 133 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | triglycerides in medium LDL measurement | 2.79e-03 | 62 | 133 | 3 | EFO_0022322 | |
| Disease | non-lobar intracerebral hemorrhage | 2.92e-03 | 63 | 133 | 3 | EFO_0010178 | |
| Disease | triglycerides in small LDL measurement | 3.19e-03 | 65 | 133 | 3 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 3.19e-03 | 65 | 133 | 3 | EFO_0021902 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 3.28e-03 | 19 | 133 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | neuroimaging measurement | DIP2B STAG1 SZT2 FRYL ELAC2 JAK1 BMP6 CXCR4 ENTPD6 PKHD1 SNTB2 PLCE1 | 3.33e-03 | 1069 | 133 | 12 | EFO_0004346 |
| Disease | total lipids in small VLDL | 3.47e-03 | 67 | 133 | 3 | EFO_0022148 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 3.47e-03 | 67 | 133 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.60e-03 | 225 | 133 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | triglycerides in very small VLDL measurement | 3.62e-03 | 68 | 133 | 3 | EFO_0022144 | |
| Disease | number of teeth measurement | 3.63e-03 | 20 | 133 | 2 | EFO_0010073 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.88e-03 | 229 | 133 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 4.00e-03 | 21 | 133 | 2 | EFO_0022277 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 4.09e-03 | 71 | 133 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.09e-03 | 71 | 133 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 4.26e-03 | 72 | 133 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | renal system measurement, blood urea nitrogen measurement | 4.39e-03 | 22 | 133 | 2 | EFO_0004741, EFO_0004742 | |
| Disease | Respiratory Hypersensitivity | 4.39e-03 | 22 | 133 | 2 | C0035228 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NQMLDWQRLKTPHGA | 51 | Q8N616 | |
| VQQWDSQVTMGHLFQ | 161 | Q12979 | |
| GEHFVNSWVQRELPM | 251 | Q13075 | |
| QVQNLSHRLWQLMGP | 116 | Q7Z4H4 | |
| DLNRQLVNMGFPQWH | 66 | Q96D05 | |
| QLQGPISKVRHMQEW | 51 | P07311 | |
| QWMIQQPHKAATFFG | 91 | P55263 | |
| PNDLWVVVFQFQHIM | 191 | P61073 | |
| FMFQLQGIHPWRTFQ | 1076 | Q9H7T0 | |
| EIINSSNGNHIFWPM | 851 | Q5SY80 | |
| VNIPHWQMAHAQGRV | 481 | Q96NN9 | |
| GNLFQRWHVPLELQM | 36 | O95831 | |
| TNFPQAHFIMQWIFQ | 606 | Q7Z2Y8 | |
| QHFNLLNEMPPTFWI | 2156 | Q8IYW2 | |
| GQTWFQHRRMLTPAF | 136 | Q02928 | |
| SPHTHQMPLWVRQIF | 336 | P11230 | |
| EPFVRMQLWLNDPHN | 1101 | O14529 | |
| RRLWMGPQFQFKTIH | 736 | Q9H6U6 | |
| PTSHQRRSWIMQALG | 1301 | Q68CQ1 | |
| SHNWNTLFMGPNAVA | 511 | Q9Y4C8 | |
| WNSLGQPHVNGRLAM | 246 | Q8N3J5 | |
| MAQQWSLQRLAGRHP | 1 | P04000 | |
| MAQQWSLQRLAGRHP | 1 | P0DN78 | |
| MVTGNLGIQWRHKPN | 316 | P23458 | |
| MAQQWSLQRLAGRHP | 1 | P0DN77 | |
| RWTAQGARPHPFQNM | 436 | P11940 | |
| IVQWLAQRMNSHGGF | 1006 | Q6IE37 | |
| WHAQVQAVFLPMAAF | 166 | Q86WK9 | |
| QHVQGPLTWQQFHKM | 1351 | Q71F56 | |
| GNAHRQIPIVHWVIM | 26 | P04201 | |
| ERLTITQFMNHPWIN | 291 | Q16644 | |
| MENQVLTPHVYWAQR | 1 | Q9P035 | |
| LHIIQRQASSQSMPW | 876 | Q8N201 | |
| VWNPRTHQFMGRTGT | 21 | P14415 | |
| NLFRMQPWLRQHLGD | 731 | P06681 | |
| LLDQHGQYPIWMNQR | 86 | Q9BRT6 | |
| MRPFLENRAQQHWGS | 61 | P49005 | |
| RNWMNSLGVNPRVNH | 401 | P13796 | |
| RTFRNWMNSLGVNPH | 401 | P13797 | |
| GLQDQHMWISIPFFI | 21 | Q8NGK2 | |
| PNWMSPSDHQRAQIN | 496 | Q6ZU69 | |
| LNITAMPHNGSFWNV | 381 | Q9UJA9 | |
| GRQVMLHYLLPWMNN | 1301 | O94915 | |
| MHQDPQLEEVIGRFW | 136 | Q8TDF6 | |
| QWRAQATPDHVLFML | 996 | Q9P265 | |
| IPEFNWSQMHQRLLT | 1306 | P50851 | |
| PNFHQASLQMSITWQ | 581 | P16050 | |
| MFRNAQITPGVQHLW | 816 | P59047 | |
| QITPGVQHLWRIVMA | 821 | P59047 | |
| QVHQVPRVFWEDGIM | 11 | Q6TCH4 | |
| PVAWTLTNIIHNLGM | 46 | Q9P0S3 | |
| SGRTQQMLVPAWQQV | 676 | Q9H422 | |
| YAMHWVRQAPGQRLE | 51 | A0A0C4DH29 | |
| QAPRVVHMLAANLTW | 346 | Q9NQS5 | |
| MGFDLQNVWRVSHIN | 166 | Q9NYA4 | |
| MNDWHRIFTQNVLVP | 1 | O75161 | |
| RVMTPYLQQRLGWHV | 186 | Q6ZVX9 | |
| MAQQWSLQRLAGRHP | 1 | P04001 | |
| SETPPHWRQEMQRAQ | 356 | Q13427 | |
| VQRYWVIVNPMGHSR | 171 | P55085 | |
| VHIVGMPFLIHQWAR | 81 | Q969V1 | |
| EQPRWMAHPAVLNAQ | 6 | P23769 | |
| VGRPNLQLQMDIFHW | 176 | Q5T013 | |
| HQGVQPAPMQRSWSQ | 136 | B1AJZ9 | |
| FTNQSLWEMPVLGQH | 66 | Q9H4Z3 | |
| PAIRERHWQQLMQAT | 1356 | Q9UFH2 | |
| RHPWITPVDNQQAMV | 281 | Q9UIK4 | |
| ARSFMVNWTHAPGNV | 366 | Q05707 | |
| RVTSSGPVINHGMWQ | 366 | Q14393 | |
| FAQMDVRQHGHPQWL | 521 | Q7Z3C6 | |
| SIMRHFGPEDQRLWN | 406 | Q9H972 | |
| GQTWFQHRRMLTPAF | 136 | Q5TCH4 | |
| MKLHWQFSQGGPIQN | 551 | Q6P9A2 | |
| AQSFGLWVPQMHKQA | 131 | Q8IX06 | |
| LWVVTPQHNMGLQLS | 316 | P22004 | |
| LWDQQHKFPVFMGRV | 481 | P05155 | |
| GFFLLQMSPKHWQIQ | 221 | Q502W7 | |
| MIHAVLQWQKRNAAP | 251 | Q9GZR7 | |
| QSMVSVLGWFANPIH | 321 | Q86Z14 | |
| GSAFLNIMWPHEIAN | 901 | Q13683 | |
| PILGWNHFMQQTSVR | 161 | P35367 | |
| MGVNNHEFSWLIPRG | 341 | Q6UWW8 | |
| WMNGQSLPMTHRLQL | 181 | Q00888 | |
| SQWFKIQHMQPSPQA | 36 | Q9H1E1 | |
| PLLSVLMWGVNHSIN | 36 | P48426 | |
| GSQELQWMVQPHFLG | 46 | P15407 | |
| RRHFQTLTVMVQAWP | 46 | Q5VWM6 | |
| LRQFQFMAWPDHGVP | 1506 | P10586 | |
| QTNMHARNLAIVWAP | 161 | Q7Z6I6 | |
| RSWIQMLQQLPQASH | 706 | Q9Y6R4 | |
| DMIARPRQPVAQWHQ | 386 | O43581 | |
| GTLHPVFARVAQRWM | 2516 | Q5T011 | |
| SPELWRQLEQHMGQR | 446 | B4DYI2 | |
| IFQQPQHGPWQTRMR | 16 | O75354 | |
| RPRWHDTAMTQIIGN | 381 | Q6UX01 | |
| RRHFQTLTVMVQAWP | 46 | Q5SWL7 | |
| TNVMRSWLFQHIGHP | 271 | P55347 | |
| IHRNTLNPMWNEQFL | 1911 | Q9P212 | |
| QNVWLNSPMRNPVHS | 116 | Q9HCM1 | |
| WMNGQSLPMSHRLQL | 181 | Q9UQ74 | |
| WMNGQSLPVTHRLQL | 181 | Q00887 | |
| TVMHGLEANPNAWLQ | 126 | Q495M3 | |
| PSFWLNHQGIQMVCE | 501 | P37173 | |
| RRHFQTLTVMVQAWP | 46 | O95521 | |
| WHFVAVQNYVNPMLA | 356 | Q8N3P4 | |
| GMRIGVQIHNTWLNP | 466 | P08F94 | |
| RHMTWIPLGNQADLF | 171 | O15160 | |
| RRHFQTLTVMVQAWP | 46 | O60811 | |
| HNVAGQWNPVFMQPL | 426 | Q12769 | |
| FRQQMKPTWRVHGII | 241 | Q8IYS1 | |
| FTPNMHILQNPRVWL | 241 | Q96N87 | |
| GLPMWQVTAFLDHNI | 26 | O00501 | |
| VQSWAFIPQDIMHGQ | 381 | Q96JI7 | |
| SLQRPNDHEFMQQPW | 376 | O15105 | |
| TQMIYQQHQSWLRPV | 46 | P00750 | |
| QWMERFGPDTQHLVL | 356 | Q9BQ52 | |
| MAWPNVFQRGSLLSQ | 1 | Q8NCC5 | |
| NKWAFQGERMIHGNP | 186 | Q03426 | |
| IIQNIPGFWMTAFRN | 271 | Q9H0U9 | |
| MIWNAQKIFHINPRL | 986 | P24928 | |
| IRSRRYWPQGMSQQH | 1106 | Q6P2S7 | |
| MAPGNLWHMRNNFLF | 21 | Q99551 | |
| FLHNPQMQISWLGQP | 1146 | Q8WVM7 | |
| PVNIHSMNFTWQAAG | 81 | Q9Y5W5 | |
| LPPDNMWSSQRFQAH | 396 | Q9Y4R7 | |
| RFQAHLQEMGAPNAW | 406 | Q9Y4R7 | |
| QWASVIRVMNPIQGN | 861 | Q15393 | |
| RVVSWLSQHNFPQGM | 791 | Q9BZ71 | |
| RQIIQQMTFGPSRWG | 876 | Q8IUG5 | |
| PAHLLVASGLQMWQV | 116 | Q96C00 | |
| VVLWMNTVGPYHNRQ | 41 | Q9HD45 | |
| QDLRSGNLWIIHPFM | 1206 | O95789 | |
| WMNGQSLPMTHRFQL | 181 | P11465 | |
| MNNAFAHLPQGVIWK | 316 | Q3SY77 | |
| EGIPICRQHLIWNNM | 61 | Q86XD8 | |
| GTQKPFWRHTVRMNL | 541 | Q96PF1 | |
| VVGIQWNHMGSVLAV | 256 | Q9P2L0 | |
| WFVAIHTNIMALLPQ | 291 | Q13425 | |
| WVLRGTAQVMFINNP | 121 | Q15849 | |
| QLQMKRWEFHNSPPA | 136 | Q9BYX2 | |
| AELAKAQPTHMQWRG | 1126 | P82987 | |
| AQPTHMQWRGIQEET | 1131 | P82987 | |
| HLAWLNQGKVLPQNM | 101 | Q93070 | |
| INMSYHPRGNWLQLR | 256 | Q93070 | |
| MRTQHWPIRLDGQQE | 191 | Q6NSJ0 |